ARTIFICIAL CLINICAL INTELLIGENCE
DEAD

Serial Number

79406972

Owner

Loon Inc.

Filing Date

Jul 5, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ARTIFICIAL CLINICAL INTELLIGENCE Trademark

Serial Number: 79406972

ARTIFICIAL CLINICAL INTELLIGENCE is a trademark filed by Loon Inc. on July 5, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 35 (Advertising & Business). The application is currently no longer active.

Owner Contact Info

Loon Inc. (2 trademarks)

101-2255 St. Laurent Blvd

Entity Type: 03

Trademark Details

Filing Date

July 5, 2024

Registration Date

Not Registered

Goods & Services

Clinical decision support software and application; computer assisted medical interventions information database recorded on computer media; computer software and software applications for accessing medical and health information; downloadable computer software for analyzing molecular and clinical data for research in the fields of medicine; downloadable podcasts in the field of healthcare, medicine, public health, infectious diseases, and medical conditions; downloadable web application software for use in search and reference of medical conditions for medical diagnostic services; electronic medical publications; software applications for mobile devices for accessing medical and health information.

Evaluation of clinical effectiveness for others; health care consultancy in the fields of public health, health assessments, and medical clinic services; information, advisory and consultancy services in the field of medical care and analysis services; information, advisory and consultancy services in the field of medical clinic services; information, advisory and consultancy services in the field of medical treatment services.

Regulatory compliance consultancy in the field of clinical trials; regulatory compliance consultancy in the field of medical biotechnology.

Analysis of market research data and statistics; business consultancy in the field of pharmaceutical leads; business management; business management advice; business management analysis; business management and administration; business management and advice; business research services; collection of market research information; collection of medical reports; compilation of statistical data for use in scientific or medical research; computerised market research services; computerized market research services; conducting business and market research services for others; interpretation of market research data; market analysis and research; market analysis and research services; market analysis and studies; market assessment services; market reports and studies; market research by means of a computer database; market research consultancy; market research services; market research studies; market studies; market study and analysis of market studies; marketing research; marketing research and analysis services; providing information about market analysis and research services; providing information about market research; providing market research information; providing marketing leads for the pharmaceutical industry; providing sales leads for the pharmaceutical industry; provision of market research information; statistical analysis and reporting services for business purposes; statistical evaluation of market research data.

Advisory services in the field of pharmacology; analysis of proteins for scientific and medical research purposes; analyzing clinical trials in the pharmaceutical, biotechnology and life sciences fields; application service provider featuring application programming interface (API) software for analyzing molecular and clinical data for scientific and medical research; biological therapeutic research services; biomedical research; biomedical research services; chemical molecular analysis, product optimization, and clinical trial services to pharmaceutical industries; computer diagnostic services for pharmacists and healthcare practitioners; computer programming in the medical field; conducting early evaluations in the field of new pharmaceuticals; conducting research, development, and evaluations in the field of new pharmaceuticals; consultancy pertaining to pharmacology; consultancy services by physicians and medical researchers in the field of virtual reality software development for use in medical, healthcare and surgical training; consulting services in the field of pharmaceutical research; design and development of virtual reality software for use in providing online collaboration environments between medical professionals; development of pharmaceutical preparations and medicines; laboratory research in the field of pharmaceuticals and nutraceuticals; maintaining and hosting databases on a global computer network for collecting and sharing results of simulated medical interventions; medical and pharmacological research services; medical research; medical research information in the fields of pharmaceuticals; medical research services; pharmaceutical drug development services; pharmaceutical evaluation services; pharmaceutical product evaluation; pharmaceutical research and development; pharmaceutical research services; pharmacological research services; platform as a service (PaaS) for searching structured and unstructured data for healthcare data analytics; platform as a service (PaaS) provider for optimizing healthcare pricing and payments; providing information about medical research; providing information relating to medical research in the field of pharmacovigilance; providing medical and scientific research information in the field of cosmetics and clinical trials; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; providing medical and scientific research information in the fields of pharmaceuticals and proteomics; providing medical research information in the field of clinical trials; providing non-downloadable computer software for use in quality assurance of the services of others in the field of pharmaceuticals and medical devices; providing online non-downloadable computer software for interpreting, displaying, managing, and sharing healthcare information, namely, test results from in vitro diagnostic devices; providing scientific research information in the fields of pharmaceuticals; providing temporary use of non-downloadable software for accessing databases in connection with research and development services in the fields of medicine; providing temporary use of non-downloadable software for accessing information for use in connection with research and development services in the fields of medicine; research and analysis in the field of medicine; research and development in the pharmaceutical and proteomics fields; research and development of vaccines and medicines; research in the field of artificial intelligence technology; research in the fields of clinical trials and post-market trials; research on the subject of pharmaceuticals; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research services in the field of pharmacovigilance; software as a service (saas) provided for accessing medical and health information; technical consulting in the field of artificial intelligence; testing of new products for others; testing of pharmaceuticals; testing, inspection and research of pharmaceuticals, cosmetics and foodstuffs.

Filing History

DEATH OF INTERNATIONAL REGISTRATION
Jun 4, 2026 DETH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 2, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 16, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Mar 16, 2026 OPNR
ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Dec 4, 2025 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Dec 4, 2025 ABN2
REFUSAL PROCESSED BY IB
Jun 7, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
May 22, 2025 RFCS
REFUSAL PROCESSED BY MPU
May 22, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 27, 2025 RFCR
NON-FINAL ACTION WRITTEN
Mar 26, 2025 CNRT
ASSIGNED TO EXAMINER
Dec 29, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Oct 18, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 18, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 17, 2024 REPR